220 related articles for article (PubMed ID: 23296549)
1. Behavioral responses to acute and sub-chronic administration of the synthetic cannabinoid JWH-018 in adult mice prenatally exposed to corticosterone.
Macrì S; Lanuzza L; Merola G; Ceci C; Gentili S; Valli A; Macchia T; Laviola G
Neurotox Res; 2013 Jul; 24(1):15-28. PubMed ID: 23296549
[TBL] [Abstract][Full Text] [Related]
2. Novel halogenated derivates of JWH-018: Behavioral and binding studies in mice.
Vigolo A; Ossato A; Trapella C; Vincenzi F; Rimondo C; Seri C; Varani K; Serpelloni G; Marti M
Neuropharmacology; 2015 Aug; 95():68-82. PubMed ID: 25769232
[TBL] [Abstract][Full Text] [Related]
3. Repeated administration of phytocannabinoid Δ(9)-THC or synthetic cannabinoids JWH-018 and JWH-073 induces tolerance to hypothermia but not locomotor suppression in mice, and reduces CB1 receptor expression and function in a brain region-specific manner.
Tai S; Hyatt WS; Gu C; Franks LN; Vasiljevik T; Brents LK; Prather PL; Fantegrossi WE
Pharmacol Res; 2015 Dec; 102():22-32. PubMed ID: 26361728
[TBL] [Abstract][Full Text] [Related]
4. Synthetic cannabinoid JWH-018 and its halogenated derivatives JWH-018-Cl and JWH-018-Br impair Novel Object Recognition in mice: Behavioral, electrophysiological and neurochemical evidence.
Barbieri M; Ossato A; Canazza I; Trapella C; Borelli AC; Beggiato S; Rimondo C; Serpelloni G; Ferraro L; Marti M
Neuropharmacology; 2016 Oct; 109():254-269. PubMed ID: 27346209
[TBL] [Abstract][Full Text] [Related]
5. Effect of JWH-250, JWH-073 and their interaction on "tetrad", sensorimotor, neurological and neurochemical responses in mice.
Ossato A; Canazza I; Trapella C; Vincenzi F; De Luca MA; Rimondo C; Varani K; Borea PA; Serpelloni G; Marti M
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jun; 67():31-50. PubMed ID: 26780169
[TBL] [Abstract][Full Text] [Related]
6. Adolescent self-administration of the synthetic cannabinoid receptor agonist JWH-018 induces neurobiological and behavioral alterations in adult male mice.
Margiani G; Castelli MP; Pintori N; Frau R; Ennas MG; Pagano Zottola AC; Orrù V; Serra V; Fiorillo E; Fadda P; Marsicano G; De Luca MA
Psychopharmacology (Berl); 2022 Oct; 239(10):3083-3102. PubMed ID: 35943523
[TBL] [Abstract][Full Text] [Related]
7. Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on "tetrad", sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies.
Canazza I; Ossato A; Trapella C; Fantinati A; De Luca MA; Margiani G; Vincenzi F; Rimondo C; Di Rosa F; Gregori A; Varani K; Borea PA; Serpelloni G; Marti M
Psychopharmacology (Berl); 2016 Oct; 233(21-22):3685-3709. PubMed ID: 27527584
[TBL] [Abstract][Full Text] [Related]
8. JWH-018 impairs sensorimotor functions in mice.
Ossato A; Vigolo A; Trapella C; Seri C; Rimondo C; Serpelloni G; Marti M
Neuroscience; 2015 Aug; 300():174-88. PubMed ID: 25987201
[TBL] [Abstract][Full Text] [Related]
9. Prenatal corticosterone and adolescent URB597 administration modulate emotionality and CB1 receptor expression in mice.
Ceci C; Mela V; Macrì S; Marco EM; Viveros MP; Laviola G
Psychopharmacology (Berl); 2014 May; 231(10):2131-44. PubMed ID: 24311359
[TBL] [Abstract][Full Text] [Related]
10. Inhalation exposure to smoke from synthetic "marijuana" produces potent cannabimimetic effects in mice.
Wiebelhaus JM; Poklis JL; Poklis A; Vann RE; Lichtman AH; Wise LE
Drug Alcohol Depend; 2012 Dec; 126(3):316-23. PubMed ID: 22776442
[TBL] [Abstract][Full Text] [Related]
11. Effects of the synthetic cannabinoid receptor agonist JWH-018 on abuse-related effects of opioids in rhesus monkeys.
Gerak LR; Weed PF; Maguire DR; France CP
Drug Alcohol Depend; 2019 Sep; 202():33-38. PubMed ID: 31295696
[TBL] [Abstract][Full Text] [Related]
12. Differential drug-drug interactions of the synthetic Cannabinoids JWH-018 and JWH-073: implications for drug abuse liability and pain therapy.
Brents LK; Zimmerman SM; Saffell AR; Prather PL; Fantegrossi WE
J Pharmacol Exp Ther; 2013 Sep; 346(3):350-61. PubMed ID: 23801678
[TBL] [Abstract][Full Text] [Related]
13. In Vivo Bio-Activation of JWH-175 to JWH-018: Pharmacodynamic and Pharmacokinetic Studies in Mice.
Tirri M; Arfè R; Bilel S; Corli G; Marchetti B; Fantinati A; Vincenzi F; De-Giorgio F; Camuto C; Mazzarino M; Barbieri M; Gaudio RM; Varani K; Borea PA; Botrè F; Marti M
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887377
[TBL] [Abstract][Full Text] [Related]
14. JWH-018 and JWH-073: Δ⁹-tetrahydrocannabinol-like discriminative stimulus effects in monkeys.
Ginsburg BC; Schulze DR; Hruba L; McMahon LR
J Pharmacol Exp Ther; 2012 Jan; 340(1):37-45. PubMed ID: 21965552
[TBL] [Abstract][Full Text] [Related]
15. Novel halogenated synthetic cannabinoids impair sensorimotor functions in mice.
Bilel S; Tirri M; Arfè R; Ossato A; Trapella C; Serpelloni G; Neri M; Fattore L; Marti M
Neurotoxicology; 2020 Jan; 76():17-32. PubMed ID: 31610187
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo pharmacological evaluation of the synthetic cannabinoid receptor agonist EG-018.
Gamage TF; Barrus DG; Kevin RC; Finlay DB; Lefever TW; Patel PR; Grabenauer MA; Glass M; McGregor IS; Wiley JL; Thomas BF
Pharmacol Biochem Behav; 2020 Jun; 193():172918. PubMed ID: 32247816
[TBL] [Abstract][Full Text] [Related]
17. Behavioral Effects of Developmental Exposure to JWH-018 in Wild-Type and Disrupted in Schizophrenia 1 (
García-González J; de Quadros B; Havelange W; Brock AJ; Brennan CH
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33669793
[TBL] [Abstract][Full Text] [Related]
18. Phase I hydroxylated metabolites of the K2 synthetic cannabinoid JWH-018 retain in vitro and in vivo cannabinoid 1 receptor affinity and activity.
Brents LK; Reichard EE; Zimmerman SM; Moran JH; Fantegrossi WE; Prather PL
PLoS One; 2011; 6(7):e21917. PubMed ID: 21755008
[TBL] [Abstract][Full Text] [Related]
19. A synthetic cannabinoid JWH-210 reduces lymphoid organ weights and T-cell activator levels in mice via CB
Gu SM; Lee HJ; Lee TH; Song YJ; Kim YH; Han KM; Shin J; Park HK; Kim HS; Cha HJ; Yun J
Naunyn Schmiedebergs Arch Pharmacol; 2017 Dec; 390(12):1201-1209. PubMed ID: 28828742
[TBL] [Abstract][Full Text] [Related]
20. Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2.
Castelli MP; Paola Piras A; D'Agostino A; Pibiri F; Perra S; Gessa GL; Maccarrone M; Pistis M
Eur J Pharmacol; 2007 Nov; 573(1-3):11-9. PubMed ID: 17644084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
